Noncatalytic Role of the FKBP52 Peptidyl-Prolyl Isomerase Domain in the Regulation of Steroid Hormone Signaling
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Hormone-dependent transactivation by several of the steroid hormone receptors is potentiated by the Hsp90-associated cochaperone FKBP52, although not by the closely related FKBP51. Here we analyze the mechanisms of potentiation and the functional differences between FKBP51 and FKBP52. While both have peptidyl-prolyl isomerase activity, this is not required for potentiation, as mutations abolishing isomerase activity did not affect potentiation. Genetic selection in Saccharomyces cerevisiae for gain of potentiation activity in a library of randomly mutated FKBP51 genes identified a single residue at position 119 in the N-terminal FK1 domain as being a critical difference between these two proteins. In both the yeast model and mammalian cells, the FKBP51 mutation L119P, which is located in a hairpin loop overhanging the catalytic pocket and introduces the proline found in FKBP52, conferred significant potentiation activity, whereas the converse P119L mutation in FKBP52 decreased potentiation. A second residue in this loop, A116, also influences potentiation levels; in fact, the FKBP51-A116V L119P double mutant potentiated hormone signaling as well as wild-type FKBP52 did. These results suggest that the FK1 domain, and in particular the loop overhanging the catalytic pocket, is critically involved in receptor interactions and receptor activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the proline-rich loop (residues 116–124) in of FKBP51 and FKBP52 is proposed to recognize different conformations of GR in regulating steroid hormone binding”
From The structure of an Hsp90-immunophilin complex reveals cochaperone recognition of the client maturation state (2021) · cites this paper as Riggs et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The FKBP52 mutation F130Y abrogates PPIase activity without disrupting the conformation of the proline-rich loop, and without inhibiting FKBP52 potentiation of AR activity alone [12].”
From The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling (2015) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“FKBP51 inhibits GR ligand binding, nuclear translocation and transcriptional activity, while FKBP52 potentiates each of these fundamental GR activities22–32.”
From Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, FKBP51 does not potentiate GR ligand binding in any of these conditions, unlike FKBP52, recapitulating in vivo findings23,29.”
From Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“unlike FKBP52, FKBP51 does not enhance GR ligand binding in vitro, consistent with in vivo studies23,27,29.”
From Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor (2023) · cites this paper as [29]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116 · cited 1×
“FKBP12 and FKBP13 form FK506-dependent complexes with calcineurin (18), which inhibits calcineurin activity and forms the basis for FK506-mediated immunosuppression.”
BackgroundMumberg, D., Müller, R., & Funk, M. (1995) · Gene · doi:10.1016/0378-1119(95)00037-7 · Cited by 1,957
Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,483
Wochnik, G. M., Rüegg, J., Abel, G. A., Schmidt, U., Holsboer, F., & Rein, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407498200 · Cited by 638
Atomic Structure of FKBP-FK506, an Immunophilin-Immunosuppressant Complex
Van Duyne, G. D., Standaert, R. F., Karplus, P. A., Schreiber, S. L., & Clardy, J. (1991) · Science · doi:10.1126/science.1709302 · Cited by 635
Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12
Huse, M., Chen, Y.-G., Massagué, J., & Kuriyan, J. (1999) · Cell · doi:10.1016/s0092-8674(00)80555-3 · Cited by 445
A New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427 · cited 2×
“Observations that FKBP52, but not FKBP51, binds to the microtubular motor protein dynein have been made (6, 26, 34), and a model has been proposed in which FKBP52 assists in directing GR to the nucleus subsequent to hormone binding (reviewed in reference 22).”
BackgroundThe Hsp90‐binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo
Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung‐Flynn, J., Prapapanich, V., Ratajczak, T., Gaber, R., Picard, D., & Smith, D. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg108 · Cited by 353 · cited 10×
“In our initial characterization of potentiation by FKBP52 (25), we presented evidence that supported a role for PPIase activity in receptor potentiation.”
BackgroundMethodInfluentialSelf-citationHop as an Adaptor in the Heat Shock Protein 70 (Hsp70) and Hsp90 Chaperone Machinery
Chen, S., & Smith, D. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35194 · Cited by 334
Self-citationRole of hsp90 and the hsp90-binding immunophilins in signalling protein movement
Pratt, W. B., Galigniana, M. D., Harrell, J. M., & DeFranco, D. B. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.02.004 · Cited by 285
Research works printed but not linked: 3
- 10.1210/endo.141.11.7785 · doi:10.1210/endo.141.11.7785 · Paper page
- 10.1128/mcb.14.3.1956-1963.1994 · doi:10.1128/mcb.14.3.1956-1963.1994 · Paper page
- 10.1128/mcb.13.2.869-876.1993 · DOI · Paper page
Cited by
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
Taipale, M., Jarosz, D. F., & Lindquist, S. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2918 · Cited by 1,818
“These functions seem to be dispensable for client activation in at least one case (that of FKBP52 -dependent potentiation of glucocorticoid receptor functio”
BackgroundSchopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540
The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones
Li, J., Soroka, J., & Buchner, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.09.003 · Cited by 498
Structure, Function and Regulation of the Hsp90 Machinery
Buchner, J., & Li, J. (2013) · Biomedical Journal · doi:10.4103/2319-4170.113230 · Cited by 420
“Interestingly, the potentiation effects do not strictly depend on the PPIase ac‐ tivity of Fkbp52 as PPIase‐deficient mutants are also able to potentiate GR transactivation, which suggests a noncatalytic role of PPIases in the regulation of SHR signaling.([52]) In contrast to Hop/Sti1 and the TPR‐PPIases, p23 is a con…”
BackgroundStructure, Function, and Regulation of the Hsp90 Machinery
Biebl, M. M., & Buchner, J. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a034017 · Cited by 304
“Strikingly, although the PPIase domain seems to be important for the function of PPIases, the enzymatic function seems to be dispensable for Hsp90-mediated client maturation (Riggs et al. 2003, 2007).”
BackgroundThe chaperone Hsp90: changing partners for demanding clients
Röhl, A., Rohrberg, J., & Buchner, J. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.02.003 · Cited by 269
FKBP51 and FKBP52 in signaling and disease
Storer, C. L., Dickey, C. A., Galigniana, M. D., Rein, T., & Cox, M. B. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.08.001 · Cited by 266
“Domain integrity in and around the PPIase pocket is essential [9].”
InfluentialSelf-citationVersatile TPR domains accommodate different modes of target protein recognition and function
Allan, R. K., & Ratajczak, T. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-010-0248-0 · Cited by 247
The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4815-09.2010 · Cited by 214
“To investigate whether FKBP51 PPIase activity specifically could affect tau biology, we generated PPIase-deficient mutants based on similar mutations previously described for FKBP52 (Riggs et al., 2007) and assayed them for PPIase activity.”
MethodSelf-citationSmith, D. F., & Toft, D. O. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0089 · Cited by 173
Self-citationFries, G., Gassen, N., & Rein, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122614 · Cited by 166
“For example, while FKBP52 potentiates GR function in the yeast model [9,74], its overexpression in mammalian cells produces very little, if any, effect on GR, likely due to the presence of numerous other TPR cofactors that already promote GR function [7,71].”
BackgroundInfluentialNi, L., Yang, C.-S., Gioeli, D., Frierson, H., Toft, D. O., & Paschal, B. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01891-08 · Cited by 155
“This result is consistent with studies from Smith and coworkers who showed that FKBP52 regulation of steroid hormone receptor activity is independent of its enzyme activity (27).”
ResultMixed Hsp90–cochaperone complexes are important for the progression of the reaction cycle
Li, J., Richter, K., & Buchner, J. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1965 · Cited by 155
Galigniana, M. D., Erlejman, A. G., Monte, M., Gomez-Sanchez, C., & Piwien-Pilipuk, G. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01190-09 · Cited by 152
“Thus, FKBP51 represses GR, PR, MR, and Aldo receptor (AR) steroid-binding capacity and transcriptional activity, whereas FKBP52 shows no significant effect on steroid receptor action or a slight activation effect if the amount of endogenous FKBP52 is sufficient (6, 21, 24, 49, 66, 67).”
BackgroundDe Leon, J. T., Iwai, A., Feau, C., Garcia, Y., Balsiger, H. A., Storer, C. L., Suro, R. M., Garza, K. M., Lee, S., Sang Kim, Y., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105160108 · Cited by 132
“Analysis of the AR LBD crystal structure revealed that these residues comprise a surface region that overlaps with the recently described AR BF3 surface (11) (Fig.”
BackgroundInfluentialSelf-citationFK506-Binding Proteins and Their Diverse Functions
Tong, M., & Jiang, Y. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519113541 · Cited by 156
“It competes with FKBP52 for binding with steroid receptors, consequently, antagonizes the positive effect of FKBP52 on these receptors [96, 121].”
BackgroundHähle, A., Merz, S., Meyners, C., & Hausch, F. (2019) · Biomolecules · doi:10.3390/biom9010035 · Cited by 119
“Pro119 as in FKBP52 supported receptor activation whereas L119 as in FKBP51 was inhibitory [15].”
BackgroundTargeting Hsp90 and its co-chaperones to treat Alzheimer’s disease
Blair, L. J., Sabbagh, J. J., & Dickey, C. A. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.943185 · Cited by 117
“Importantly, FKBP51 and FKBP52 do differ at key residues which could be exploited for drug design [126].”
BackgroundAssimon, V. A., Southworth, D. R., & Gestwicki, J. E. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00801 · Cited by 112
Periyasamy, S., Hinds, T., Shemshedini, L., Shou, W., & Sanchez, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.458 · Cited by 108
“It should be noted, however, that the most recent data from studies of GR show that mutations that abrogate the PPIase function of FKBP52 do not block FKBP52 potentiation of GR (Riggs et al., 2007).”
BackgroundDifferential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors
Schülke, J.-P., Wochnik, G. M., Lang-Rollin, I., Gassen, N. C., Knapp, R. T., Berning, B., Yassouridis, A., & Rein, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011717 · Cited by 105
“While the PPIase protein domains of FKBP51 and FKBP52 play an important role in GR’s regulation, the function of the enzymatic PPIase activity remains enigmatic [18,21,28].”
BackgroundMultidomain Peptidyl Prolyl cis/trans Isomerases
Schiene‐Fischer, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.012 · Cited by 120
The prospect of FKBP51 as a drug target
Schmidt, M. V., Paez‐Pereda, M., Holsboer, F., & Hausch, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200137 · Cited by 99
Annett, S., Moore, G., & Robson, T. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107623 · Cited by 111
Chaperoning steroidal physiology: Lessons from mouse genetic models of Hsp90 and its cochaperones
Sanchez, E. R. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.11.006 · Cited by 94
“Its intrinsic PPIase activity is not required for GR, since enzymatically dead mutants of FKBP52 still exert positive effects on the GR [56].”
BackgroundBiological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Zgajnar, N., De Leo, S., Lotufo, C., Erlejman, A., Piwien-Pilipuk, G., & Galigniana, M. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 94
“Although the PPIase activity is not necessary for enhancing AR activity, the FK1 catalytic pocket appears to be essential in potentiating the AR response to androgens via [105], such that treatments with FK506 reduce AR binding capacity and prevents the androgen-induced proliferation of prostate cancer cells.”
BackgroundFKBP51 – a selective modulator of glucocorticoid and androgen sensitivity
Stechschulte, L. A., & Sanchez, E. R. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.012 · Cited by 92
“In the case of GR, the PPIase activities of both FKBP51 and FKBP52 are not required for their modulatory functions [26].”
BackgroundFluorescent Probes to Characterise FK506‐Binding Proteins
Kozany, C., März, A., Kress, C., & Hausch, F. (2009) · ChemBioChem · doi:10.1002/cbic.200800806 · Cited by 91
Prolyl isomerases in gene transcription
Hanes, S. D. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.10.028 · Cited by 104
Lee, K., Thwin, A. C., Nadel, C. M., Tse, E., Gates, S. N., Gestwicki, J. E., & Southworth, D. R. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.07.023 · Cited by 76
Prolyl Isomerization and Its Catalysis in Protein Folding and Protein Function
Schmidpeter, P. A. M., & Schmid, F. X. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.023 · Cited by 96
Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52)
Sivils, J. C., Storer, C. L., Galigniana, M. D., & Cox, M. B. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.010 · Cited by 81
Self-citationGaligniana, N. M., Ballmer, L. T., Toneatto, J., Erlejman, A. G., Lagadari, M., & Galigniana, M. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07775.x · Cited by 77
The Hsp90 chaperone machinery: from structure to drug development
Hahn, J. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.10.623 · Cited by 82
Functional principles and regulation of molecular chaperones
Dahiya, V., & Buchner, J. (2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2018.10.001 · Cited by 76
Diverse structures, functions and uses of FK506 binding proteins
Bonner, J. M., & Boulianne, G. L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.06.013 · Cited by 82
Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor
Noddings, C. M., Johnson, J. L., & Agard, D. A. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01128-y · Cited by 75
“2b and 4c) 29 , which we investigated further below.”
BackgroundResultInfluentialBaker, J. D., McMillan, I. O., Ospina, S. R., Gulick, D., & Blair, L. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010079 · Cited by 79
“FKBP4, the gene that encodes the highly similar FKBP51 homolog, FKBP52, may have an opposing effect on GR activity; however, conflicting evidence suggests FKBP52 may not alter GR nuclear transactivation [32,35,36,65,66].”
BackgroundFKBP51 and the molecular chaperoning of metabolism
Smedlund, K., Sánchez, E. R., & Hinds, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.003 · Cited by 75
Focus on FKBP51: A molecular link between stress and metabolic disorders
Häusl, A. S., Balsevich, G., Gassen, N. C., & Schmidt, M. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.003 · Cited by 78
“While the FK1 domain is important for GR regulation, its biochemical activity is not [54].”
BackgroundModulating FKBP5/FKBP51 and autophagy lowers HTT (huntingtin) levels
Bailus, B. J., Scheeler, S. M., Simons, J., Sanchez, M. A., Tshilenge, K., Creus‐Muncunill, J., Naphade, S. B., Lopez‐Ramirez, A., Zhang, N., Madushani, K. L., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1904489 · Cited by 78
Balsiger, H. A., de la Torre, R., Lee, W., & Cox, M. B. (2010) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2009.12.027 · Cited by 69
“Thus, the yeast-based steroid hormone receptor-mediated reporter assay using a chemiluminescent substrate has been used extensively for the analysis of receptor regulatory proteins (Balsiger and Cox, 2009; Cox et al., 2007; Riggs et al., 2007; Riggs et al., 2003).”
MethodSelf-citationPeptidyl‐prolylcis‐transisomerase ROF2 modulates intracellular pH homeostasis in Arabidopsis
Bissoli, G., Niñoles, R., Corrales, S. F., Palombieri, S., Bueso, E., Rubio, L., García‐Sánchez, M. J., Fernández, J. A., Mulet, J. M., & Serrano, R. (2012) · The Plant Journal · doi:10.1111/j.1365-313x.2012.04921.x · Cited by 68
“This “stoichiometric” mechanism seems to apply in the interaction of animal cyclophilin A with rhodopsin (Baker et al., 1994), HIV-1 Gag protein (Luban, 1996) and chemotaxis receptor CD147 (Song et al., 2011) and in the case of mammalian FKBP52 and steroid hormone receptor (Riggs et al., 2007).”
BackgroundOrganization and function of the FKBP52 and FKBP51 genes
Cioffi, D. L., Hubler, T. R., & Scammell, J. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.03.013 · Cited by 65
“Thus, amino acid and structural differences are likely responsible for the antagonistic activities of the two proteins on steroid receptor activity [14,15].”
Dose- and time-dependent glucocorticoid receptor signaling in podocytes
Guess, A. J., Agrawal, S., Wei, C., Ransom, R. F., Benndorf, R., & Smoyer, W. E. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00161.2010 · Cited by 66
Rein, T. (2016) · BioEssays · doi:10.1002/bies.201600050 · Cited by 64
“All three mutations abolished PPIase activity, but retained FKBP52 stimulatory function on GR [36].”
BackgroundEvaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Gaali, S., Kress, C., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201746x · Cited by 64
Molecular Cochaperones: Tumor Growth and Cancer Treatment
Calderwood, S. K. (2013) · Scientifica · doi:10.1155/2013/217513 · Cited by 68
“Although structurally similar, these two Hsp90 co-chaperones appear to have opposing effects on nuclear receptor transcriptional activity, with the tightly binding FKBP1 inhibiting activity and the more loosely associated FKBP2 activating at least in the case of MR, GR, PR and AR [134, 137].”
BackgroundInfluentialIncreasing the efficiency of ligands for FK506-binding protein 51 by conformational control
Wang, Y., Kirschner, A., Fabian, A.-K., Gopalakrishnan, R., Kress, C., Hoogeland, B., Koch, U., Kozany, C., Bracher, A., & Hausch, F. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400087k · Cited by 60
Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90
Bracher, A., Kozany, C., Thost, A.-K., & Hausch, F. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911013862 · Cited by 62
“…per se does not appear to be necessary for steroid hormone receptor modulation, a single amino-acid swap at the periphery of the FK506-binding site (L119P) was sufficient to diminish and partially reverse the inhibitory or stimulatory effect of FKBP51 and FKBP52, respectively (Riggs et al., 2007).”
BackgroundFKBP51 Reciprocally Regulates GRα and PPARγ Activation via the Akt-p38 Pathway
Stechschulte, L. A., Hinds, T. D., Ghanem, S. S., Shou, W., Najjar, S. M., & Sánchez, E. R. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1023 · Cited by 69
Song, D., Li, L.-S., Heaton-Johnson, K. J., Arsenault, P. R., Master, S. R., & Lee, F. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.440552 · Cited by 61
Malekpour, M., Shekouh, D., Safavinia, M. E., Shiralipour, S., Jalouli, M., Mortezanejad, S., Azarpira, N., & Ebrahimi, N. D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1182345 · Cited by 85
“The remaining 25% difference between these two proteins potentially affects their conformation and domain orientation and, consequently, their divergent effects on steroid hormone receptor (SHR) activities (48, 49).”
BackgroundCoregulator control of androgen receptor action by a novel nuclear receptor-binding motif
Jehle, K., Cato, L., Neeb, A., Muhle-Goll, C., Jung, N., Smith, E. W., Buzon, V., Carbó, L. R., Estébanez-Perpiñá, E., Schmitz, K., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.534859 · Cited by 53
“80), (41-80) and (61-80) were generated by PCR amplification of Bag-1L and cloned into the pGex4T.”
BackgroundMethodInfluentialSelf-citationFKBP51 Controls Cellular Adipogenesis through p38 Kinase-Mediated Phosphorylation of GRα and PPARγ
Stechschulte, L. A., Hinds, T. D., Khuder, S. S., Shou, W., Najjar, S. M., & Sánchez, E. R. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1022 · Cited by 55
Exploration of pipecolate sulfonamides as binders of the FK506-binding proteins 51 and 52
Gopalakrishnan, R., Kozany, C., Wang, Y., Schneider, S., Hoogeland, B., Bracher, A., & Hausch, F. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201747c · Cited by 52
Gollan, P. J., Bhave, M. R., & Aro, E. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.002 · Cited by 56
Genome-wide analysis of genes encoding FK506-binding proteins in rice
Gollan, P. J., & Bhave, M. R. (2009) · Plant Molecular Biology · doi:10.1007/s11103-009-9547-1 · Cited by 55
“In several non-lumenal FKBPs the loop regions, particularly the ‘40s’ and ‘80s’ loops, have shown to provide interaction sites for specific protein partners (Griffith et al. 1995; Ivery and Weiler 1997; Samso et al. 2006; Riggs et al. 2007; Galat 2008), suggesting that variability in the lumenal FKBPs may infer divers…”
BackgroundBracher, A., Kozany, C., Hähle, A., Wild, P., Zacharias, M., & Hausch, F. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.041 · Cited by 45
Sunnotel, O., Hiripi, L., Lagan, K., McDaid, J. R., Leon, J. T. D., Miyagawa, Y., Crowe, H., Kaluskar, S., Ward, M. S., Scullion, C. A., et al. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-22 · Cited by 43
“FKBP52 has one functional PPI domain, but catalytic activity may not actually be required for FKBP52-mediated regulation of AR function [16].”
BackgroundSelf-citationBanasavadi‐Siddegowda, Y., Mai, J., Fan, Y., Bhattacharya, S., Giovannucci, D. R., Sánchez, E. R., Fischer, G. S., & Wang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.269993 · Cited by 47
Promotion of Myoblast Differentiation by Fkbp5 via Cdk4 Isomerization
Ruiz-Estevez, M., Staats, J., Paatela, E., Munson, D., Katoku-Kikyo, N., Yuan, C., Asakura, Y., Hostager, R., Kobayashi, H., Asakura, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.006 · Cited by 39
“Fkbp5FD67DV lacked PPIase activity due to the replacement of the two amino acids FD with DV at the mouth of the PPIase pocket, potentially causing a major conformational change of the PPIase domain (Barent et al., 1998; Riggs et al., 2007).”
BackgroundThe prolyl isomerase, FKBP25, interacts with RNA-engaged nucleolin and the pre-60S ribosomal subunit
Gudavicius, G., Dilworth, D., Serpa, J. J., Sessler, N., Petrotchenko, E. V., Borchers, C. H., & Nelson, C. J. (2014) · RNA · doi:10.1261/rna.042648.113 · Cited by 41
“However, there are examples in which this is not the case, and prolyl isomerases function independent of catalytic activity (ArévaloRodríguez et al. 2004; Riggs et al. 2007).”
BackgroundShi, D., Bai, Q., Zhou, S., Liu, X., Liu, H., & Yao, X. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25401 · Cited by 38
“The hydrophobic interactions between b4–b5 loop and b21b3a strands seem to constrain the movement of b4–b5 loop 21 and affect the functional consequence of FKBPs in steroid receptor complex.(64) In order to evaluate hydrophobic interactions between b4–b5 loop and b21b3a strands, the residue-residue contacts between b4…”
BackgroundDahiya, V., Rutz, D. A., Moessmer, P., Mühlhofer, M., Lawatscheck, J., Rief, M., & Büchner, J. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.016 · Cited by 40
A specialized Hsp90 co-chaperone network regulates steroid hormone receptor response to ligand
Backe, S. J., Sager, R., Regan, B., Sit, J., Major, L., Bratslavsky, G., Woodford, M. R., Bourboulia, D., & Mollapour, M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111039 · Cited by 40
“The Hsp90 co-chaperones FKBP51 and -52 are also specialized SHR co-chaperones that regulate SHR maturation and play a role in translocation of ligand-bound SHR to the nucleus (Guy et al., 2015; Mazaira et al., 2021; Riggs et al., 2007).”
Wolf, I. M., Periyasamy, S., Hinds, T., Yong, W., Shou, W., & Sanchez, E. R. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.11.006 · Cited by 38
“Yet, the latest data suggest that mutations which abrogate the PPIase function of FKBP52 do not block the potentiation of GR [55].”
BackgroundHsp90 can accommodate the simultaneous binding of the FKBP52 and HOP proteins
Hildenbrand, Z. L., Molugu, S. K., Herrera, N., Ramirez, C., Xiao, C., & Bernal, R. A. (2011) · Oncotarget · doi:10.18632/oncotarget.225 · Cited by 38
“These findings reveal that FKBP52-mediated potentiation of receptor activity is significantly abrogated in glucocorticoid (GR), androgen (AR) and progesterone (PR) receptor models [34, 42-45].”
BackgroundXAP2 inhibits glucocorticoid receptor activity in mammalian cells
Laenger, A., Lang‐Rollin, I., Kozany, C., Zschocke, J., Zimmermann, N., Rüegg, J., Holsboer, F., Hausch, F., & Rein, T. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.072 · Cited by 47
Functions of the Hsp90-Binding FKBP Immunophilins
Guy, N. C., Garcia, Y. A., Sivils, J. C., Galigniana, M. D., & Cox, M. B. (2015) · Subcellular Biochemistry · doi:10.1007/978-3-319-11731-7_2 · Cited by 35
“…studies in S. cerevisiae demonstrated that two point mutations (A116V and L119P) in the FKBP51 FK1 domain, which does not potentiate steroid hormone receptor activity under normal conditions, confer full receptor potentiating ability to FKBP51, similar to that of FKBP52 (Riggs et al. 2007).”
BackgroundResultInfluentialSelf-citationWu, D., Tao, X., Chen, Z., Han, J., Jia, W.-J., Zhu, N., Li, X., Wang, Z., & He, Y. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2015.12.045 · Cited by 37
Steroid Receptor-Associated Immunophilins: A Gateway to Steroid Signalling.
Ratajczak, T., Cluning, C., & Ward, B. K. (2015) · Europe PMC (PubMed Central) · Cited by 41
FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
Maeda, K., Habara, M., Kawaguchi, M., Matsumoto, H., Hanaki, S., Masaki, T., Sato, Y., Matsuyama, H., Kunieda, K., Nakagawa, H., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13030 · Cited by 32
Lallous, N., Leblanc, E., Munuganti, R. S. N., Hassona, M. D. H., Nakouzi, N. A., Awrey, S. J., Morin, H., Roshan‐Moniri, M., Singh, K., Lawn, S. O., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0354 · Cited by 32
“We identified a PARTPP motif in the SGTA sequence (residues 78–83) that is very similar to the sequences of FKPB52 (GSAGSPP) and BAG1L (GARRPR), shown to interact with the BF3 region of AR (15, 16, 30).”
BackgroundMethodThe Role of p23, Hop, Immunophilins, and Other Co-chaperones in Regulating Hsp90 Function
Cox, M. B., & Johnson, J. L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-295-3_4 · Cited by 35
Self-citationUnraveling the Role of Peptidyl-Prolyl Isomerases in Neurodegeneration
Gérard, M., Deleersnijder, A., Demeulemeester, J., Debyser, Z., & Baekelandt, V. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8184-2 · Cited by 36
The known unknowns of the Hsp90 chaperone
Silbermann, L., Vermeer, B., Schmid, S., & Tych, K. M. (2024) · eLife · doi:10.7554/elife.102666 · Cited by 34
Kamah, A., Cantrelle, F., Huvent, I., Giustiniani, J., Guillemeau, K., Byrne, C., Jacquot, Y., Landrieu, I., Baulieu, E. E., Smet‐Nocca, C., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.02.015 · Cited by 29
Altınok, S., Sanchez‐Hodge, R., Stewart, M., Smith, K., & Schisler, J. C. (2021) · Cells · doi:10.3390/cells10113121 · Cited by 27
“Whereas PPIase inhibition may be therapeutically effective in cancer, in AD models, there are PPIase-independent activities of FKBP51 and FKBP52 that appear to be important [223,235].”
BackgroundThe helix 1–3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones
Cluning, C., Ward, B. K., Rea, S. L., Arulpragasam, A., Fuller, P. J., & Ratajczak, T. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1023 · Cited by 26
Chen, Y., Terajima, M., Banerjee, P., Guo, H., Liu, X., Jiang, Y. L., Yamauchi, M., & Kurie, J. M. (2017) · Scientific Reports · doi:10.1038/srep46021 · Cited by 30
Mustafi, S. M., LeMaster, D. M., & Hernández, G. (2014) · Biochemical Journal · doi:10.1042/bj20140232 · Cited by 25
“Using a yeast heterologous expression system for the human androgen receptor, Riggs et al. [17] demonstrated that a L119P mutation in the first FKBP domain (FK1) of human FKBP51 yielded a 3.5-fold increase in reporter gene expression.”
InfluentialPeptidylprolylisomerases, Protein Folders, or Scaffolders? The Example of FKBP51 and FKBP52
Rein, T. (2020) · BioEssays · doi:10.1002/bies.201900250 · Cited by 25
Dilworth, D., Gudavicius, G., Xu, X., Boyce, A. K. J., O’Sullivan, C., Serpa, J. J., Bilenky, M., Petrotchenko, E. V., Borchers, C. H., Hirst, M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky008 · Cited by 25
“While there are good examples to support this model (9,10,96,97), a growing body of literature demonstrates that these proteins also have noncatalytic impacts on biological processes, presumably via direct binding events (27,28,98,99).”
BackgroundDilworth, D., Gudavicius, G., Leung, A., & Nelson, C. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-045 · Cited by 25
Regulation of FKBP51 and FKBP52 functions by post-translational modifications
Daneri-Becerra, C., Zgajnar, N. R., Lotufo, C. M., Ramos-Hryb, A. B., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190334 · Cited by 24
Baischew, A., Engel, S., Taubert, M. C., Geiger, T. M., & Hausch, F. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01098-1 · Cited by 22
“Several studies have pointed towards a key role of the FK1 domains 31–33 , in particular the proline-rich loop around L/P119 overhanging the FK506-binding site 31 .”
Biological relevance of Hsp90‐binding immunophilins in cancer development and treatment
Mazaira, G. I., Camisay, M. F., Leo, S. A. D., Erlejman, A. G., & Galigniana, M. D. (2015) · International Journal of Cancer · doi:10.1002/ijc.29509 · Cited by 25
“Hence, an FKBP51 mutant containing two point mutations (A116 V and L119P) in the FKBP51 proline-rich loop showed full FKBP52-like activity towards AR.83 Moreover, the exchange of both PPIase domains in chimeric proteins transforms FKBP52 into FKBP51 and vice versa.15 Thus, the replacement of the N-terminal domain in F…”
BackgroundHinds, T. D., Stechschulte, L. A., Elkhairi, F., & Sanchez, E. R. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.76 · Cited by 20
“Interestingly, this effect is not controlled by the PPIase function of FKBP52, as enzymatically dead mutants of FKBP52 can still bind FK506 and potentiate GR (Riggs et al. 2007).”
BackgroundErlejman, A. G., Lagadari, M., Harris, D. C., Cox, M. B., & Galigniana, M. D. (2014) · Current Protein and Peptide Science · doi:10.2174/1389203715666140331113753 · Cited by 25
Self-citationMulti-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer
Sun, Z., Qin, X., Fang, J., Tang, Y., & Fan, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697534 · Cited by 25
“FKBP4 acts as a positive regulator of steroid receptors (19).”
BackgroundUnique Proline-Rich Domain Regulates the Chaperone Function of AIPL1
Li, J., Žoldák, G., Kriehuber, T., Soroka, J., Schmid, F. X., Richter, K., & Büchner, J. (2013) · Biochemistry · doi:10.1021/bi301648q · Cited by 22
Evidence for Hsp90 Co-chaperones in Regulating Hsp90 Function and Promoting Client Protein Folding
Cox, M. B., & Johnson, J. L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7477-1_28 · Cited by 23
Self-citationStocki, P., Sawicki, M., Mays, C. E., Hong, S. J., Chapman, D. C., Westaway, D. A., & Williams, D. B. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-10-0729 · Cited by 25
Ilaslan, E., Markosyan, R. L., Sproll, P., Stevenson, B. J., Sajek, M., Sajek, M. P., Hayrapetyan, H., Sarkisian, T., Лившиц, Л. А., Nef, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218403 · Cited by 17
Ratajczak, T. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519113639 · Cited by 18
LeMaster, D. M., Mustafi, S. M., Brecher, M. B., Zhang, J., Heroux, A., Li, H., & Hernández, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.650655 · Cited by 21
Regulation of store-operated calcium entry by FK506-binding immunophilins
Kadeba, P. I., Vasauskas, A. A., Chen, H., Wu, S., Scammell, J. G., & Cioffi, D. L. (2013) · Cell Calcium · doi:10.1016/j.ceca.2012.12.008 · Cited by 17
“In the case of the glucocorticoid receptor, the FK1 domain but not PPIase activity of FKBP52 is required for receptor activation [63].”
BackgroundCato, L., Neeb, A., Brown, M. A., & Cato, A. C. B. (2014) · Nuclear Receptor Signaling · doi:10.1621/nrs.12005 · Cited by 17
“Another interesting observation is that mutation of the GARRPR motifs in both proteins results in a gain-of-function phenotype [89,93].”
BackgroundInactivation of ID 4 promotes a CRPC phenotype with constitutive AR activation through FKBP 52
Joshi, J., Patel, D., Morton, D. J., Sharma, P., Zou, J., Bostanthirige, D. H., Gorantla, Y., Nagappan, P., Komaragiri, S. K., Sivils, J. C., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12028 · Cited by 17
Self-citation
Metadata
- Authors
- Riggs, D. L., Cox, M. B., Tardif, H. L., Hessling, M., Buchner, J., & Smith, D. F.
- Affiliations
- Mayo Clinic in Arizona (US)
- Technical University of Munich (DE)
- Institut fur Organische Chemie und Biochemie, Technische Universitat Munchen
- Corresponding author
- Smith, David F.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2007-12
- Volume
- 27
- Issue
- 24
- Pages
- 8658-8669
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2169416
- OpenAlex
- W2102874036
- Semantic Scholar
- 40336ca6d307d443895b6424372ffd5d3efb36c6
- Cited by
- 150
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 4 · 2021: 9 · 2020: 4 · 2019: 10 · 2018: 4 · 2017: 9 · 2016: 5 · 2015: 13 · 2014: 15 · 2013: 12 · 2012: 12
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK48218, R01DK048218, F32DK068983)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- FKBP52, FKBP51, peptidyl-prolyl isomerase, steroid hormone receptors, Hsp90 co-chaperone, FK1 domain, stem-loop structure, receptor potentiation
- MeSH terms
- Tacrolimus Binding Protein 5, Amino Acid Sequence, Animals, Catalysis, Drug Synergism, Models, Molecular, Molecular Sequence Data, Mutation, Recombinant Fusion Proteins, Selection, Genetic, Steroids, Structure-Activity Relationship, Signal Transduction, Protein Structure, Tertiary, Peptidylprolyl Isomerase, Tacrolimus Binding Proteins, Mutant Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.